Co-delivery of an Optimal Drug/siRNA Combination Using Mesoporous Silica Nanoparticle to Overcome Drug Resistance in Breast Cancer In Vitro and In Vivo

We used a multi-functional mesoporous silica nanoparticle (MSNP) carrier to overcome doxorubicin (Dox) resistance in a multidrug resistant (MDR) human breast cancer xenograft by co-delivering Dox and siRNA that targets the P-glycoprotein (Pgp) drug exporter. The Pgp siRNA selection from among a seri...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Meng, Huan, Mai, Wilson X., Zhang, Haiyuan, Xue, Min, Xia, Tian, Lin, Sijie, Wang, Xiang, Zhao, Yang, Ji, Zhaoxia, Zink, Jeffrey I., Nel, Andre E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3620006/
https://ncbi.nlm.nih.gov/pubmed/23289892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/nn3044066
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak